Thermo Fisher Scientific Stock: Analyst Estimates & Ratings

Thermo Fisher Scientific Stock: Analyst Estimates & Ratings Aritra Gangopadhyay Mon, August 17, 2026 at 10:31 AM EDT 2 min read TMO ^GSPC Thermo Fisher Scientific location_By jetcityimage Waltham, Massachusetts-based Thermo Fisher Scientific Inc. (TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. The company has a market cap of $217.5 billion and operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Shares of Thermo Fisher have slightly lagged behind the broader market over the past year, surging 20.3% compared to the S&P 500 Index's ($SPX) 20.4% surge. Moreover, in 2026, the stock has grown by nearly 1.5%, also underperforming SPX's 13.7% gain. More News from Barchart A $210 Billion Reason to Buy AMD Stock Here CoreWeave vs Nebius: Both Companies Reported Strong Earnings, But Here's the Stock You Should Buy As Oracle Deepens Its Partnership with AWS, Here's How You Should Play ORCL Stock Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Zooming in further, the State Street Healthcare Select Sector SPDR ETF (XLV) has risen 22.4% over the past year, outperforming the stock. In 2026, XLV has surged 7.7% and outpaced the stock. www.barchart.com Analyst…